EMEA-001501-PIP05-20

Key facts

Invented name
Dupixent
Active substance
dupilumab
Therapeutic area
Dermatology
Decision number
P/0304/2020
PIP number
EMEA-001501-PIP05-20
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of bullous pemphigoid
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Regeneron Ireland DAC

Tel. +1 9148 475385
E-mail: clinicaltrials@regeneron.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Related content

How useful was this page?

Add your rating